Target
Illuminate
Cure

Innovative fluorescence imaging against cancer.

SurgiMab is a clinical-stage biotechnology company at the forefront of real-time cancer detection.

Our mission is to improve cancer care through innovative imaging solutions that support earlier detection, better decision making and more effective treatment.

More Precise Surgeries

Surgeons can remove all cancerous tissue while preserving healthy tissue, reducing recurrence risks.

Fewer Complications & Faster Recovery

Less invasive procedures mean reduced side effects, shorter hospital stays, and faster healing.

Better Long-Term Outcomes

Lower chances of cancer recurrence, improved survival rates, and enhanced quality of life.

Earlier and More Accurate Detection

Improved screening leads to earlier diagnosis, increasing treatment success rates.

Pipeline

Tumor targeting fluorescent molecules, engineered to target any solid tumor.

Our values

Innovation

Continuously developing and applying new ideas to drive progress.

Excellence

Committing to the highest standards in everything we do.

Collaboration

Working together across teams and disciplines to achieve common goals.

Patient-centered care

Prioritizing human connection, accessibility, and personalized care.